Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Slingluff

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Cancer Immunology, Immunotherapy : CII|September 29, 1999
Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanismsC L Slingluff
Seminars in Surgical Oncology|November 1, 1996
Tumor antigens and tumor vaccines: peptides as immunogensC L Slingluff
Seminars in Surgical Oncology|May 1, 1993
Malignant melanoma and the prognostic implications of pregnancy, oral contraceptives, and exogenous hormonesC L Slingluff, D Reintgen
Annals of Plastic Surgery|January 11, 1992
"Thin" malignant melanoma: risk factors and clinical managementC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Immunotherapy for malignant melanoma with a tumor cell vaccineC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Anorectal melanoma: clinical characteristics and the role of abdominoperineal resectionC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Malignant melanoma and pregnancyC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Prospects for cellular immunotherapy for metastatic melanomaC L Slingluff, H F Seigler
The American Surgeon|October 1, 1990
Toxic shock syndrome after inguinal hernia repair. Report of a case with patient survivalC L Slingluff, W W Burns, C Cooperberg
Current Oncology Reports|December 21, 2000
Vaccination for melanomaL W Thompson, L Brinckerhoff, C L Slingluff
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|September 29, 1999
Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanismsC L Slingluff
Seminars in Surgical Oncology|November 1, 1996
Tumor antigens and tumor vaccines: peptides as immunogensC L Slingluff
Seminars in Surgical Oncology|May 1, 1993
Malignant melanoma and the prognostic implications of pregnancy, oral contraceptives, and exogenous hormonesC L Slingluff, D Reintgen
Annals of Plastic Surgery|January 11, 1992
"Thin" malignant melanoma: risk factors and clinical managementC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Immunotherapy for malignant melanoma with a tumor cell vaccineC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Anorectal melanoma: clinical characteristics and the role of abdominoperineal resectionC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Malignant melanoma and pregnancyC L Slingluff, H F Seigler
Annals of Plastic Surgery|January 11, 1992
Prospects for cellular immunotherapy for metastatic melanomaC L Slingluff, H F Seigler
The American Surgeon|October 1, 1990
Toxic shock syndrome after inguinal hernia repair. Report of a case with patient survivalC L Slingluff, W W Burns, C Cooperberg
Current Oncology Reports|December 21, 2000
Vaccination for melanomaL W Thompson, L Brinckerhoff, C L Slingluff
Pageof 6